Twist Bioscience Corporation, A Company Enabling Customers To Succeed Through Its Offering Of High-Quality Synthetic Dna Using Its Silicon Platform, And Kriya Therapeutics, Inc., A Fully Integrated Company Pioneering Novel Technologies And Therapeutics In Gene Therapy, Today Announced An Antibody Discovery Agreement For Antibodies Delivered Using Adeno-Associated Viral (Aav) Gene Therapy In Therapeutic Oncology Applications.
